Intensity Therapeutics Inc. INTS
3.80
(0.21)
(5.24%)
as of 25 Sep
- Market cap
- $12.7M
- P/E
- 0.0×
Follow INTS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|
Current Ratio |
5.92 | 1.92 | 3.91 | 0.21 | 1.27 | 7.04 | 7.67 |
Net Debt/EBITDA |
0.99 | 0.15 | 1.83 | 0.18 | 0.56 | 1.47 | 1.43 |
Debt/Assets |
0.56% | 2.30% | 0.80% | 0.00% | 2.75% | 3.21% | 2.89% |
Debt/Equity |
0.01 | 0.04 | 0.01 | 0.00 | 0.11 | 0.04 | 0.03 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.80 | 0.94 | 0.61 | 0.72 | 0.86 | 0.89 | 0.82 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (156.90%) | (202.34%) | 1,225.41% | 63.76% | 154.16% | 312.47% | 0.00% | |
| (122.92%) | (147.37%) | (124.52%) | (217.46%) | (102.77%) | (62.96%) | 0.00% | |
ROIC |
(22,007.35%) | (2,366.58%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(109.87%) | (1,011.69%) | (103.10%) | 141.24% | (782.05%) | (74.16%) | (69.21%) |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Free Cash Flow per Share |
(6.81) | (27.37) | (20.91) | (40.15) | (25.03) | (19.69) | (0.34) |
Cash per Share |
8.79 | 4.66 | 42.88 | 9.62 | 16.64 | 34.15 | 0.64 |
Shareholders Equity per Share |
8.76 | 5.25 | 38.20 | (37.38) | 4.82 | 30.94 | 0.59 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.76 | 5.25 | 38.20 | (37.38) | 4.82 | 30.94 | 0.59 |
Free Cash Flow |
(9.23) | (15.22) | (7.20) | (5.48) | (6.83) | (5.37) | (4.42) |
Working Capital |
10.56 | 1.61 | 11.51 | (5.37) | 1.01 | 8.13 | 7.52 |
Net Current Asset Value |
10.48 | 1.50 | 11.33 | (5.40) | 0.83 | 7.77 | 7.34 |
| Other line items | |||||||
Quick Ratio |
5.56 | 1.48 | 3.73 | 0.19 | 1.22 | 6.92 | 7.47 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(38.67%) | (270.91%) | (25.66%) | 144.66% | (113.81%) | (29.70%) | (28.55%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(6.81) | (27.37) | (20.91) | (40.15) | (25.03) | (19.69) | (0.34) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | 0.06 | 0.06 | 0.05 | — |
Average Payables |
0.90 | 2.13 | 1.83 | 0.39 | 0.20 | 0.31 | — |
Average Assets |
9.44 | 11.04 | 9.53 | 3.49 | 7.68 | 9.58 | — |
Average Common Equity |
7.40 | 8.04 | (0.97) | (11.89) | (5.12) | (1.93) | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates